154 related articles for article (PubMed ID: 26662940)
1. Assessing value-based health care delivery for haemodialysis.
Parra E; Arenas MD; Alonso M; Martínez MF; Gamen Á; Aguarón J; Escobar MT; Moreno-Jiménez JM; Alvarez-Ude F
J Eval Clin Pract; 2017 Jun; 23(3):477-485. PubMed ID: 26662940
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of dialysis centres: values and criteria of the stakeholders.
Parra E; Arenas MD; Fernandez-Reyes Luis MJ; Blasco Forcén A; Alvarez-Ude F; Aguarón Joven J; Altuzarra Casas A; Moreno-Jiménez JM
BMC Health Serv Res; 2020 Apr; 20(1):297. PubMed ID: 32290836
[TBL] [Abstract][Full Text] [Related]
3. Outcomes weighting for comprehensive haemodialysis centre assessment.
Parra E; Arenas MD; Alonso M; Martínez MF; Gamen A; Balda S; Rebollo P; Martínez T; Álvarez-Ude F
Nefrologia; 2012; 32(5):659-63. PubMed ID: 23013953
[TBL] [Abstract][Full Text] [Related]
4. Appendix to dialysis centre guidelines: recommendations for the relationship between outpatient haemodialysis centres and reference hospitals. Opinions from the Outpatient Dialysis Group. Grupo de Trabajo de Hemodiálisis Extrahospitalaria.
Berdud I; Arenas MD; Bernat A; Ramos R; Blanco A;
Nefrologia; 2011; 31(6):664-9. PubMed ID: 22130281
[TBL] [Abstract][Full Text] [Related]
5. Effect of a quality improvement strategy on several haemodialysis outcomes.
Parra E; Ramos R; Betriu A; Paniagua J; Belart M; Martínez T
Nephrol Dial Transplant; 2008 Sep; 23(9):2943-7. PubMed ID: 18372391
[TBL] [Abstract][Full Text] [Related]
6. Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.
MacLeod A; Daly C; Khan I; Vale L; Campbell M; Wallace S; Cody J; Donaldson C; Grant A
Cochrane Database Syst Rev; 2001; (3):CD003234. PubMed ID: 11687058
[TBL] [Abstract][Full Text] [Related]
7. Quality of life in end stage renal disease: a multicentre comparative study.
Gayle F; Soyibo AK; Gilbert DT; Manzanares J; Barton EN
West Indian Med J; 2009 Jun; 58(3):235-42. PubMed ID: 20043531
[TBL] [Abstract][Full Text] [Related]
8. Variability in quality of care among dialysis units in western Switzerland.
Saudan P; Halabi G; Perneger T; Wasserfallen JB; Kossovsky M; Feldman H; Martin PY; Wauters JP;
Nephrol Dial Transplant; 2005 Sep; 20(9):1854-63. PubMed ID: 15998646
[TBL] [Abstract][Full Text] [Related]
9. Rationale and design for SHAREHD: a quality improvement collaborative to scale up Shared Haemodialysis Care for patients on centre based haemodialysis.
Fotheringham J; Barnes T; Dunn L; Lee S; Ariss S; Young T; Walters SJ; Laboi P; Henwood A; Gair R; Wilkie M
BMC Nephrol; 2017 Nov; 18(1):335. PubMed ID: 29178891
[TBL] [Abstract][Full Text] [Related]
10. Economic evaluation of centre haemodialysis and continuous ambulatory peritoneal dialysis in Ministry of Health hospitals, Malaysia.
Hooi LS; Lim TO; Goh A; Wong HS; Tan CC; Ahmad G; Morad Z
Nephrology (Carlton); 2005 Feb; 10(1):25-32. PubMed ID: 15705178
[TBL] [Abstract][Full Text] [Related]
11. Review article: Use of renal registry data for research, health-care planning and quality improvement: what can we learn from registry data in the Asia-Pacific region?
Lim TO; Goh A; Lim YN; Morad Z
Nephrology (Carlton); 2008 Dec; 13(8):745-52. PubMed ID: 19154324
[TBL] [Abstract][Full Text] [Related]
12. An evaluation of the costs, effectiveness and quality of renal replacement therapy provision in renal satellite units in England and Wales.
Roderick P; Nicholson T; Armitage A; Mehta R; Mullee M; Gerard K; Drey N; Feest T; Greenwood R; Lamping D; Townsend J
Health Technol Assess; 2005 Jul; 9(24):1-178. PubMed ID: 15985188
[TBL] [Abstract][Full Text] [Related]
13. Identifying critically important vascular access outcomes for trials in haemodialysis: an international survey with patients, caregivers and health professionals.
Viecelli AK; Howell M; Tong A; Teixeira-Pinto A; O'Lone E; Ju A; Craig JC; Hooi LS; Lee T; Lok CE; Polkinghorne KR; Quinn RR; Vachharajani TJ; Vanholder R; Zuo L; Tordoir J; Pecoits-Filho R; Yuo T; Kopperschmidt P; Smith R; Irish AB; Mori TA; Pascoe EM; Johnson DW; Hawley CM
Nephrol Dial Transplant; 2020 Apr; 35(4):657-668. PubMed ID: 31369099
[TBL] [Abstract][Full Text] [Related]
14. Outcomes and cost-effectiveness of initiating dialysis and continuing aggressive care in seriously ill hospitalized adults. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments.
Hamel MB; Phillips RS; Davis RB; Desbiens N; Connors AF; Teno JM; Wenger N; Lynn J; Wu AW; Fulkerson W; Tsevat J
Ann Intern Med; 1997 Aug; 127(3):195-202. PubMed ID: 9245224
[TBL] [Abstract][Full Text] [Related]
15. Attainment of clinical performance targets and improvement in clinical outcomes and resource use in hemodialysis care: a prospective cohort study.
Plantinga LC; Fink NE; Jaar BG; Sadler JH; Levin NW; Coresh J; Klag MJ; Powe NR
BMC Health Serv Res; 2007 Jan; 7():5. PubMed ID: 17212829
[TBL] [Abstract][Full Text] [Related]
16. Challenges and barriers to managing quality in an end-stage renal disease facility.
VanValkenburgh D; Snyder S
Am J Kidney Dis; 1994 Aug; 24(2):337-45. PubMed ID: 8048442
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the quality of care of a haemodialysis public-private partnership programme for patients with end-stage renal disease.
Chen JY; Wan EY; Chan KH; Chan AK; Chan FW; Lam CL
BMC Nephrol; 2016 Jul; 17(1):79. PubMed ID: 27401348
[TBL] [Abstract][Full Text] [Related]
18. Standardised outcomes in nephrology - Haemodialysis (SONG-HD): study protocol for establishing a core outcome set in haemodialysis.
Tong A; Manns B; Hemmelgarn B; Wheeler DC; Tugwell P; Winkelmayer WC; van Biesen W; Crowe S; Kerr PG; Polkinghorne KR; Howard K; Pollock C; Hawley CM; Johnson DW; McDonald SP; Gallagher MP; Urquhart-Secord R; Craig JC;
Trials; 2015 Aug; 16():364. PubMed ID: 26285819
[TBL] [Abstract][Full Text] [Related]
19. Two-Year Outcomes of Early Cannulation Arteriovenous Grafts for End-Stage Renal Disease.
Desai SS
Ann Vasc Surg; 2019 Aug; 59():158-166. PubMed ID: 31009720
[TBL] [Abstract][Full Text] [Related]
20. Low dose erythropoietin in maintenance haemodialysis: improvement in quality of life and reduction in true cost of haemodialysis.
Harris DC; Chapman JR; Stewart JH; Lawrence S; Roger SD
Aust N Z J Med; 1991 Oct; 21(5):693-700. PubMed ID: 1759917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
